國家衛生研究院 NHRI:Item 3990099045/2904
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 852779      Online Users : 317
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/2904


    Title: Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase
    Authors: Wei, SJ;Chao, Y;Shih, YL;Yang, DM;Hung, YM;Yang, WK
    Contributors: National Institute of Cancer Research
    Abstract: Transduction of cancer cells with herpes simplex virus thymidine kinase gene (HSVtk) followed by prodrug ganciclovir (GCV) treatment has been shown to induce apoptosis. In this study, four murine tumors including B16F10 melanoma, NG4TL4 sarcoma, H6 hepatoma and 1MEA 7R.1 hepatoma were found to vary in sensitivity to this gene therapy strategy in vitro but, at effective doses of GCV, the HSVtk-transduced cells of all four tumors showed similar kinetics of early rise in p53 protein levels, then cell cycle S-/G2-phase arrest and finally signs of apoptosis. Immunoblot analyses revealed that Pas (CD95/APO-1), Pas ligand (FasL) and two downstream mediators, RIP and caspase-3 (CPP32, YAMA, Apopain) were increased in GCV-treated HSVtk-transduced tumor cells after the cell cycle arrest and before apoptosis. Increased expression of Fast could also be observed in vivo in HSVtk-transduced tumors induced to regress by GCV treatment. Enzyme measurements using specific substrate showed that the caspase-3 activation followed kinetically the Fast expression. More than half of the HSVtk/GCV-induced cell death could be abrogated by addition to the cell culture medium of a specific antisense oligonucleotide to block Fast synthesis, a recombinant Pas/Fc chimeric protein to compete with Pas receptor for Fast binding, or cell-permeable specific tetrapeptide inhibitors of caspase-3 or caspase-8.
    Keywords: Biochemistry & Molecular Biology;Biotechnology & Applied Microbiology;Genetics & Heredity;Medicine, Research & Experimental
    Date: 1999-03
    Relation: Gene Therapy. 1999 Mar;6(3):420-431.
    Link to: http://dx.doi.org/10.1038/sj.gt.3300817
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0969-7128&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000079002400015
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0033067561
    Appears in Collections:[Wen-Kuang Yang(1996-1999)] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    000079002400015.pdf581KbAdobe PDF925View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback